Minireview
Statistical analysis of drug-drug and site-site interactions with isobolograms

https://doi.org/10.1016/0024-3205(89)90148-3Get rights and content

Abstract

The use of more than one drug to achieve a desired effect has been a common practice in pharmacologic testing and in clinical practice. For example, combinations of analgesics are frequently prescribed with a view to enhancing pain relief and reducing adverse effects. It is also well established that administration of more than one drug may give effects that are greater than, or less than, the additive effect of each drug given individually. A non-mechanistic method of characterizing the effect resulting from the Administration of two compounds is the isobologram. It is relatively simple to draw and interpret isobolograms. However, this graphical technique, which employs equieffective concentrations of individual drugs and combinations of these, obtains the concentrations as random variables from concentration-effect data, usually transformed to a parallel line assay. Thus, statistical confidence limits from such assays, as well as from non-parallel designs, must be expressed on the isobologram if this diagram is to establish superadditive, subadditive, or merely additive effects. We now present a detailed statistical analysis of the isobolographic method illustrated with examples of the statistical procedures, a rational basis for selecting proportions of each drug in the combination, and a relatively novel application of the isobolographic concept, i.e., interactions involving different anatomical sites.

References (23)

  • R.J. Tallarida et al.

    Life Sci.

    (1979)
  • R.B. Busby et al.

    J. Theor. Biol.

    (1981)
  • Q. Jiang et al.

    Life Sci.

    (1987)
  • S.C. Roerig et al.

    Brain Res.

    (1984)
  • Q. Jiang et al.

    Gastroenterology

    (1988)
  • S. Loewe et al.

    Nauyn-Schmiedeberg's Arch. Exp. Path. Pharmacol.

    (1926)
  • P.K. Gessner et al.

    J. Pharmacol. Exp. Ther.

    (1970)
  • P.K. Gessner
  • S. Loewe

    Arzneim. Forsch.

    (1953)
  • S. Loewe

    Pharmacol. Rev.

    (1957)
  • S. Loewe

    Arzneim. Forsch.

    (1959)
  • Cited by (347)

    • Better antidepressant efficacy of mecamylamine in combination with L-NAME than with L-arginine

      2020, Behavioural Brain Research
      Citation Excerpt :

      The dose-effect curve was constructed and the experimental points fitted using least-squares linear regression. Then, the ED50 (50 % immobility time) of each drug was calculated [19,20]. To assess the interaction between drugs, mecamylamine and NO agents were administered in fixed-ratio combination (mecamylamine ED50/2 + NO agent ED50/2 mg/kg; mecamylamine ED50/4 + NO agent ED50/4 mg/kg and mecamylamine ED50/8 + NO agent ED50/8 mg/kg).

    View all citing articles on Scopus
    View full text